Wikidata entity: Q65352829
Quantities
| P4135 | maximum age | 85 |
| P2899 | minimum age | 65 |
| P1132 | number of participants | 97 |
| P17 | country | ... | Q30 (United States) | United States |
| P17 | country | ... | Q801 (Israel) | Israel |
| P582 | end time | ... | 2017-12-25 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P1050 | medical condition | ... | Q57859955 (cognitive dysfunction) | cognitive dysfunction |
| P6153 | research site | ... | Q30270172 (Memory Enhancement Center of America) | Memory Enhancement Center of America |
| P6153 | research site | ... | Q50035554 (Pharmacology Research Institute) | Pharmacology Research Institute |
| P6153 | research site | ... | Q50036830 (Lehigh Center for Clinical Research) | Lehigh Center for Clinical Research |
| P6153 | research site | ... | Q500606 (University of South Florida) | University of South Florida |
| P580 | start time | ... | 2014-09-01 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | A, Multi-center, Double-blind, Randomized, Placebo-controlled Study for the Efficacy of Phosphatidylserine in Mild Cognitive Impairment (MCI) | ??? |
| P3098 | ClinicalTrials.gov ID | NCT02211560 |
Why not click here or view trends?
log id: 3914351